Interest in adrenal medullary function has been revived in recent years by the demonstration that the adrenal medulla produces two hormones, epinephrine and nor-epinephrine. Nor-epinephrine, which is also produced by adrenergic nerves (1), differs in its chemical structure from epinephrine by the absence of an N-methyl group, and is the probable precursor of epinephrine. The observation by Goldenberg, Faber, Alston, and Chargaff (2) that adrenal medullary extract from cattle (natural epinephrine, U.S.P.) contained up to 18 per cent nor-epinephrine was confirmed by Tullar (3) and Auerbach and Angell (4). Subsequently, nor-epinephrine was found in varying proportions in the adrenal medullary extracts of several mammalian species, including man, and it has been shown that the majority of pheochromocytomas contain larger amounts of nor-epinephrine than of epinephrine (5).
Interest in adrenal medullary function has been revived in recent years by the demonstration that the adrenal medulla produces two hormones, epinephrine and nor-epinephrine. Nor-epinephrine, which is also produced by adrenergic nerves (1) , differs in its chemical structure from epinephrine by the absence of an N-methyl group, and is the probable precursor of epinephrine. The observation by Goldenberg, Faber, Alston, and Chargaff (2) that adrenal medullary extract from cattle (natural epinephrine, U.S.P.) contained up to 18 per cent nor-epinephrine was confirmed by Tullar (3) and Auerbach and Angell (4) . Subsequently, nor-epinephrine was found in varying proportions in the adrenal medullary extracts of several mammalian species, including man, and it has been shown that the majority of pheochromocytomas contain larger amounts of nor-epinephrine than of epinephrine (5) .
Although the cardiovascular effects of these hormones in man have been well established (6) , there are few studies concerning their comparative metabolic effects. It is highly probable that in many of the early studies of the circulatory and metabolic effects of epinephrine, mixtures which contained varying proportions of nor-epinephrine were used, since it was demonstrated in 1948 that adrenal medullary extract from cattle produced a rise in blood sugar in the rabbit comparable to that obtained with a mixture of 75 per cent epinephrine and 25 per cent nor-epinephrine, rather than that obtained with pure epinephrine (7) .
The similarity of the responses which occur during insulin hypoglycemia to those produced ' The work described in this paper was aided in part by grants from the Life Insurance Medical Research Fund and the Georgia Heart Association. by the administration of epinephrine, and the presence of increased amounts of epinephrine in the blood and urine during hypoglycemia (8, 9) , have led to the general belief that increased adrenal medullary secretion during insulin hypoglycemia is in part responsible for the symptoms produced and for spontaneous recovery of the blood glucose level. This is further suggested by the observation in rats that a rise in blood lactic acid, similar to that which results from the administration of epinephrine, also occurs during insulin hypoglycemia. The lactic acidemia induced by hypoglycemia can be prevented by adrenal medullectomy (10) .
This study was undertaken 1) to evaluate certain metabolic and circulatory effects of pure epinephrine and nor-epinephrine in man and to compare these effects with those induced by insulin hypoglycemia, and 2) to determine the effect of an autonomic blocking agent on certain circulatory and metabolic changes which occur during insulin hypoglycemia in order to throw light on the mechanisms involved in these changes.
MATERIAL AND METHODS
All subjects were free of metabolic or cardiovascular disease and fasted for at least 12 hours without physical activity or sedation. Throughout the study, blood pressure was measured at one-minute intervals by the auscultatory method. Pulse rate was measured every five minutes and electrocardiograms were obtained at frequent intervals. Lactic acid and glucose (as total reducing substance) were determined in duplicate in copper tungstate filtrates prepared from venous blood. Glucose was measured by the Nelson method (11) and lactic acid by a modification of the Barker-Summerson method (12 was added as a preservative. Appropriate dilutions with saline were made from these stock solutions. Following a one-hour control period, .085 mcg. per kg. per min. of epinephrine was administered intravenously with a Bowman constant infusion pump to eight subjects for a 50-minute period. Two blood samples were obtained during the control period and single samples at 15-minutes intervals during and after the infusion period. In order to evaluate dose responses, the infusions were repeated in the same subjects on a subsequent day under similar conditions except that the quantity of epinephrine was doubled (.170 mcg. per kg. per min.) . 4 The effects of nor-epinephrine .170 mcg. per kg. per min. were studied in a similar manner in four subjects. Double this dosage of nor-epinephrine was attempted, but had to be discontinued because of severe side effects.
In order to determine whether the circulatory and metabolic changes induced by administered epinephrine were affected by an autonomic blocking agent, hexamethonium 5 (100 mg.) was administered intravenously to three subjects before beginning an infusion of .085 mcg. per kg. per min. of epinephrine. Three additional sub4The doses of epinephrine and nor-epinephrine originally planned for this study were 0.10 mcg. per kg. per min. and 0.20 mcg. per kg. per min. Subsequent to completion of the study constant weighing and calculation errors were discovered which necessitated correction to the accurate dosage values. jects were given a rapid intravenous injection of 400 mg. of tetraethylammonium chloride 6 (TEAC) before and again during the infusion.
Insulin hypoglycemia was induced in five subjects with 15 units of regular insulin intravenously after a one-hour control period. Hypoglycemia was terminated with intravenous glucose 50 minutes later. Four blood samples were obtained during the control period, and single samples at ten-minute intervals during the insulin period, and at 15-minute intervals after glucose was begun. On a subsequent day, insulin hypoglycemia was again induced in the same subjects following the administration of 100 mg. of hexamethonium intravenously during the last ten minutes of the control period.
RESULTS
Striking differences in both the circulatory and metabolic effects of epinephrine and nor-epinephrine were observed. Epinephrine produced an increase in the pulse pressure accompanied by tachycardia and T-wave changes in the electrocardiogram. These circulatory changes were accompanied by an increase in blood glucose and lactic acid as summarized in Table I . Neither hexamethonium nor TEAC had any effect on either was stopped, the blood pressure and pulse promptly returned to control values. The electrocardiograms taken on six subjects during the infusion showed a decreased amplitude of the T-waves in four and inversion of the T-waves in two; the QT interval was prolonged in five. These changes were more marked with the larger dose, and disappeared in from thirty to sixty minutes after the infusion was discontinued.
The effects of epinephrine on blood glucose and lactic acid are shown in Figure 2 . The peak rise in glucose occurred 45 minutes after the infusion was started; a mean rise of 45 mg. per cent was observed with .085 mcg. per kg. per min. and 59 mg. per cent with the larger dose. Comparisons of the rise in glucose above individual control values at the two-dose levels show a significant difference at 45 and 60 minutes, indicating a dose response relationship with respect to blood glucose.
The maximum rise in blood lactic acid occurred ten minutes after the infusion of .085 mcg. per kg. per min. of epinephrine was ended and five minutes before the infusion with the larger dose was ended. The smaller dose produced a mean increase of 9.8 mg. per cent above the control value, while the large dose resulted in a mean increase of 17.2 mg. per cent above the control value. The differences between the elevations of lactic acid obtained with the two doses of epinephrine are statistically significant at the 15, 30, 45 and 60-minute periods after the start of the infusion, and suggest a dose response relationship with respect to lactic acid.
Hexamethonium and TEAC had no effect on the circulatory or metabolic effects of epinephrine. In the three subjects who received hexamethonium prior to the infusion, blood glucose (average) increased 62 mg. per cent above the control level, and blood lactic acid 10.8 mg. per cent. Similar results were obtained in the three subjects who received TEAC before and during the infusion.
Nor-epinephrine
In Figure 3 are shown the mean changes in blood pressure and pulse rate in the four sub- Figure 2 and Table II The mean blood glucose and lactic depicted in Figure 2 .
Insiulin hypoglycemia
The circulatory changes which occurred during insulin hypoglycemia and the effect of hexamethonium on these changes are shown in Figure 4 . Between 20 and 30 minutes after the administration of insulin, profuse sweating, hunger sensations and mild palpitation occurred in all subjects; simultaneous with these symptoms, the systolic blood pressure began to rise, the diastolic began to fall, and the heart rate increased. The T-wave in the electrocardiogram decreased in amplitude or inverted. The maximum changes in blood pressure and pulse were observed a few minutes before glucose was given, and pulse increased from 75 to 90 per minute. The circulatory changes and symptoms disappeared, rapidly after the hypoglycemia was terminated; however, the T-wave changes persisted for as long as one hour.
During and following the intravenous administration of hexamethonium, all subjects developed signs of autonomic blockade as manifested by dryness of the mouth. dilatation and fixation of the acid responses in these subjects are pupils to light, absence of sweating, and increase in the pulse rate and a slight fall in blood pressure. Following the administration of insulin and during the hypoglycemic period the signs of autonomic blockade were maintained. The blood pressure, which continued to fall and reached its lowest level at the time when widening of the pulse pressure occurred with insulin alone, showed a mean maximum fall of 28 mm. Hg systolic and 20 mm. Hg diastolic from the control level. There was no further increase in pulse rate from that produced by the hexamethonium. Changes in the electrocardiogram similar to those observed with insulin alone also occurred. Hunger sensations were not abolished but were milder.
In Figure 5 are shown the metabolic changes which occurred during insulin hypoglycemia together with the effect of hexamethonium on these changes. Following insulin alone, the mean glucose level showed a steady fall during the first 40 minutes of the hypoglycemic period and then rose spontaneously before intravenous glucose was given. Blood lactic acid rose to 20.7 mg. per cent 573 (a significant rise from the control value) at the same time the spontaneous rise in glucose occurred.
After autonomic blockade with hexamethonium, insulin produced a greater hypoglycemic effect. During the last ten minutes of the insulin period, the blood glucose continued to fall, in marked contrast to the spontaneous rise observed at this time with insulin alone. Despite the further fall in glucose, the mean maximum rise in lactic acid during the hypoglycemic period was only 2.0 mg. per cent above the control value. As shown in Table  III , individual variations in the lactic acid responses following blockade with hexamethonium showed considerable latitude in comparison with the changes in blood glucose, which were more consistent.
Changes in blood glucose similar to those observed in the present study with insulin alone and insulin with hexamethonium have been reported in man by Laurence and Stacey (14) and by Schachter in dogs (15) . 
DISCUSSION
In the first published report on the comparative hemodynamic effects of epinephrine and nor-epinephrine in man Goldenberg, Pines, Baldwin, Greene, and Roh (6) demonstrated that the pressor properties of these hormones result from different mechanisms. Epinephrine in doses sufficient to affect the blood pressure causes overall vasodilatation, a decrease in the peripheral resistance, a striking increase in the cardiac output and an increase in the heart rate due to direct cardiac stimulation. As a result, the systolic blood pressure becomes elevated but the diastolic pressure remains unchanged or falls. In contrast, norepinephrine causes overall vasoconstriction with consequent increase in the peripheral resistance, and no change in the cardiac output. Thus elevation of both systolic and diastolic pressure occurs. The heart rate is slowed by nor-epinephrine, presumably because of increased vagal tone, since the bradvcardia may be abolished by atropine. FIGuRE 4 Note that after hexamethonium the hypoglycemic effect was greater, the blood glucose failed to rise at 50 minutes and the blood lactic acid rise was inhibited.
Electrocardiographic changes similar to those observed with epinephrine in this study have been reported by other investigators (16, 17) and may be related to changes in serum potassium or to the effects of this hormone on the myocardium (18, 19) .
The circulatory and metabolic changes produced by infused epinephrine are quite similar to those observed here during insulin hypoglycemia, suggesting that adrenal medullary secretion of epinephrine is stimulated during hypoglycemia in man. Rise of the blood lactic acid and spontaneous recovery of the blood sugar curve are thereby accounted for on the basis of an induced epinephrinemia. The release of epinephrine in significant amounts from the adrenal medulla appears to be related to the degree of hypoglycemia. To judge from the blood lactic acid responses here presented, the secretion of epinephrine has begun when the blood glucose concentration reaches levels of approximately 50 mg. per cent.
In the rat, mild insulin hypoglycemia does not Both hexamethonium and TEAC block transmission through autonomic ganglia. Hexamethonium was given before insulin because the blockade persists for well over one hour, whereas that produced by TEAC is much shorter in duration. The prevention by hexamethoniulmi of the epinephrine-like changes induced by insulin hypoglycemia may be interpreted as indicating inhibition of adrenal medullary secretion of epinephrine. since neither hexamethonium nor TEAC affected the responses to administered epinephrine. The most likely site of block is the medulla itself. since it may be considered a moidified ganglion and is supplied by pre-ganglionic fibers.
Billington, Paton, Reynolds. and Sherlock (20) in similar studies used initramuiiiscular hexamethonium bromide (1 mg. per Kg.) and intravenous insulin (0.1 unit per kg.) given simtultaneously. They were unable to prevent arterial lactic acidemia and did not observe either enhancement of hypoglycemia or failure of spontaneous recovery of the blood sugar. However, they did note inhibition of the expected rise in hepatic glucose output and splanchnic oxygen consumption and thereby postulated a partial block of epinephrine release by hexamethonium. It appears likely that the smaller dose of hexamethonium they employed or slower absorption from the intramuscular injection (whereas insulin was given intravenously at the same time) produced an incomplete block or allowed epinephrine to be released from the adrenal medulla before effective hexamethonium blockade was achieved.
The similarity of the electrocardiographic changes following insulin alone and insulin preceded by hexamethonium are of interest. The fact that these changes were not affected following hexamethonium despite the prevention of other changes (luring hypoglycemia suggests that epinephrine was not responsible and that some other mechanism may be involved.
The release of epinephrine by the adrenal medulla as an immediate or emergency response to moderate or severe hypoglycemia in man seems demonstrated by our data. The further fall in blood glucose and inhibition of the lactic acid response by hexamethonium indicate that this emergency response was prevented by blockade of the adrenal medulla. It is probable that ultimate recoverv of the blood glucose level by other mechanisms would have occurred had the hypoglycemia not been terminated. It has been suggested that one such mechanism may be a direct glycogenolytic response of the liver to hypoglycemia (21) this may be the major factor which determines spontaneous recovery of the glucose level (22) .
The observation that the blood lactic acid levels rise in response to epinephrine but are not influenced by nor-epinephrine may be of aid in evaluating the relative amount of epinephrine production b1 pheochromocytomas. SUMNIMARY AND CONCLUSIONS 1. A comparative study of the effects of epinephrine and nor-epinephrine on the blood pressure, pulse rate, electrocardiogram, blood glucose and lactic acid is presented.
2. Epinephrine influences the circulation mainly through its cardiac effects, while norepinephrine acts mainly on the peripheral vessels.
3. Epinephrine induces a significant rise in blood glucose and lactic acid while nor-epinephrine does not affect these significantly.
4. The reported circulatory and metabolic changes induced by insulin hypoglycemia are qualitatively similar to these seen with the administration of epinephrine.
5. Whereas the circulatory and metabolic effects of administered epinephrine are not influenced by ganglionic blockade of the autonomic nervous system with hexamethonium or TEAC, these same effects are prevented by hexametho-576 nium followed by insulin hypoglycemia, suggesting that the main pharmacologic action of these agents on the adrenal medulla is a blocking one.
6. The electrocardiographic effects induced by epinephrine, nor-epinephrine and insulin hypoglycemia are presented.
7. Blood lactic acid levels may be of aid in recognizing the presence of pheochromocytomas which produce mainly epinephrine.
